Quantifying Uterine Elastography in Menstruating Women
This study is looking at the elasticity (stretchiness) of the female reproductive organs, including the uterus, cervix, and ovaries, in women with normal menstrual cycles. Researchers will use a special ultrasound technique called shear wave elastography to measure these elasticities at different times during your menstrual cycle. The goal is to create a standard range for normal elasticity, which could help doctors diagnose and predict outcomes for women seeking fertility treatment in the future. You may be eligible if you are a woman between 18 and 45 years old, have normal menstrual cycles and uterine anatomy, and have no prior pregnancies or known infertility. This is an observational study, meaning you will not receive any experimental treatments. The study plans to enroll 40 participants, but its current recruitment status is unclear.
- Study design
- This is an observational study that plans to enroll 40 women. It is not a randomized or blinded study.
- What's involved
- You would have shear wave elastography measurements taken via ultrasound at different times during your menstrual cycle. The primary measurements will be taken 3-4 months after you join the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your shear wave elastography parameters will be measured at 3-4 months from enrollment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NCT06816381
Quantifying Uterine Elastography in Menstruating Women
Recruiting
Not specifiedAges 18–45ObservationalReproductive Medicine Associates of New JerseyInvestigator-initiated
~40 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:Shear wave elastography measurements
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Shear wave elastography parameters
Measured over 3-4 months from enrollment
Conditions
Where it's being run
1 sites across 1 statesNew Jersey1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients with normal menstrual cycles lasting 28-34 days
Patients with normal uterine anatomy
Patients with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries
Patient who have no known infertility (i.e. women who have not tried to conceive)
Patients with normal menstrual cycles lasting 28 days to 34 days.
Patients with normal uterine and ovarian anatomy (absence of gross pathology on screening visit ultrasound)
Patients with at least one prior full-term vaginal delivery with time to conception less than one year without the use of assisted reproductive technology.
Patients with normal menstrual cycles lasting 28 days to 34 days.
Patients with normal uterine and ovarian anatomy (absence of gross pathology on screening visit ultrasound)
Patient with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries (i.e gravity equals zero).
Patient with diagnosis of primary infertility, with attempted conception for at least 12 months if younger than 35 years and attempted conception for at least 6 months if 35 years or older.
Exclusion
BMI ≥ 35
Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of -endometrioma)
History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
Currently present or surgically corrected uterine anomalies
Ultrasound evidence of or history of communicating hydrosalpinx
Ultrasound evidence of or history of leiomyomas
Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
BMI ≥ 35
Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
History of cesarean section
Patient who have no known secondary infertility (i.e. women who have not tried to conceive)
Diagnosis of secondary infertility (i.e women who have attempted pregnancy for 12 months without success)
History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of endometrioma)
History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
Currently present or surgically corrected uterine anomalies
Ultrasound evidence of or history of communicating hydrosalpinx
Ultrasound evidence of or history of leiomyomas
Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
BMI ≥ 35
Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
History of three or more failed euploid embryo transfers
Severe male factor infertility including severe oligozoospermia and cryptozoospermia
History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of endometrioma)
History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
Currently present or surgically corrected uterine anomalies
Ultrasound evidence of or history of communicating hydrosalpinx
Ultrasound evidence of or history of leiomyomas
Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
What this trial measures
- Shear wave elastography parameters3-4 months from enrollment
shear wave elastography measurements in kilopascals